Point72 Hong Kong LTD Vericel Corp Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $66,168 - $114,089	2,892 New	2,892 $73,000
Q1 2021 May 17, 2021	SELL	$30.93 - $59.48 $26,321 - $50,617	-851 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $15,769 - $26,806	851 New	851 $26,000
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $7,824 - $10,190	-533 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $12,869 - $23,951	-1,514 Reduced 73.96%	533 $7,000
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $14,840 - $39,343	2,047 New	2,047 $19,000
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $313 - $416	-21 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $315 - $396	21 New	21 $0
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $226 - $387	-21 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $764 - $1,243	-84 Reduced 80.0%	21 $0
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $1,008 - $1,533	105 New	105 $1,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.